文献速递膀胱癌与上尿路尿路上皮癌

蓝光膀胱镜对尿细胞学检查性能的影响

Effect of blue-light cystoscopy on contemporary performance of urine cytology.
PubMed 文献 · BJU Int · 2018-10-21

该研究基于三项前瞻性研究的个体患者数据,评估当代尿细胞学检查的性能及增强膀胱镜技术的影响。共分析1 487份尿样,总体细胞学灵敏度40.8%、特异度92.8%,低级别肿瘤灵敏度11.4%、高级别54.3%,白光与蓝光膀胱镜间灵敏度无差异。

要点

  • 尿细胞学对高级别肿瘤和原位癌的灵敏度仍较低。
  • 蓝光膀胱镜未显著影响细胞学总体灵敏度,但原位癌亚组有降低趋势。
  • 以细胞学作为膀胱镜主要辅助手段可能遗漏复发早期检测机会。

核心结论

  • 基于当代数据,尿细胞学检测高级别肿瘤和原位癌的灵敏度仍低。
  • 按患者分析,先进膀胱镜技术未影响细胞学灵敏度,但原位癌患者除外。

研究设计与样本

  • 研究获取三项前瞻性研究的个体患者数据:Photocure B305和B308研究评估蓝光膀胱镜联合六氨基乙酰丙酸酯,Cxbladder监测研究评估Cxbladder监测测试。
  • 共纳入1 375例患者的1 487份尿样,检出615个肿瘤,对应41%的细胞学标本。

主要发现

  • 细胞学汇总灵敏度为40.8%,特异度为92.8%。
  • 低级别/WHO 1级疾病灵敏度为11.4%,高级别/WHO 3级疾病灵敏度为54.3%。
  • 白光膀胱镜和蓝光膀胱镜联合六氨基乙酰丙酸酯的细胞学灵敏度分别为41.3%和40.4%,无差异。
  • 原位癌亚组分析显示蓝光膀胱镜联合六氨基乙酰丙酸酯的细胞学灵敏度为54.5%,白光膀胱镜为69.2%,呈降低趋势。

临床怎么用

  • 在高风险患者中,以尿细胞学作为膀胱镜的主要辅助手段可能导致复发早期检测遗漏。
  • 细胞学可能影响判断患者对膀胱内治疗(如卡介苗)无应答的机会。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the performance of urine cytology based on contemporary data, including the effect of enhanced cystoscopic techniques. MATERIALS AND METHODS: Individual patient data were obtained from three prospective studies: the Photocure (PC) B305 and the PC B308 studies, evaluating the use of blue-light cystoscopy with hexaminolevulinate (BLC-H), and the Cxbladder monitoring study, evaluating the Cxbladder monitor test for the detection of recurrent urothelial carcinoma. The specificity and sensitivity of cytology in each study and for the overall cohort were calculated. RESULTS: A total of 1 487 urine samples from 1 375 patients were included in the analysis; overall 615 tumours were detected correlating to 41% of the cytological specimens. The pooled sensitivity and specificity for cytology were 40.8% and 92.8%, respectively. The pooled sensitivity was 11.4% for low-grade/World Health Organization (WHO) grade 1 disease and 54.3% for high-grade/WHO grade 3 disease. There were no differences in cytology sensitivity based on the type of cystoscopy used, with sensitivity of 41.3% and 40.4% in white-light cystoscopy (WLC) and BLC-H, respectively. Subgroup analysis including carcinoma in situ ( CIS) showed a trend towards lower cytology sensitivity in BLC-H (54.5%) vs WLC (69.2%). CONCLUSIONS: Based on analysis of contemporary data, the sensitivity of cytology for detecting high-grade tumours and CIS remains low. On a per-patient analysis, cytology sensitivity was not affected by the use of advanced cystoscopic techniques except in patients with CIS. The use of cytology as the main adjunct to cystoscopy in patients at high risk can lead to missed opportunities for early detection of recurrence and for determining which patients are not responding to intravesical therapies such as bacille Calmette-Guérin.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Freifeld Y, Lotan Y. Effect of blue-light cystoscopy on contemporary performance of urine cytology. BJU Int. 2018. PMID: 30281893. doi:10.1111/bju.14574

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。